Moneta Group Investment Advisors’s Arbutus Biopharma ABUS Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Shares Change % | Capital Flow | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2025
Q2 | $80.3K | Hold |
26,000
| – | – | ﹤0.01% | 693 |
|
|
2025
Q1 | $90.7K | Hold |
26,000
| – | – | ﹤0.01% | 652 |
|
|
2024
Q4 | $85K | Buy |
26,000
+1,000
| +4% | +$3.27K | ﹤0.01% | 650 |
|
|
2024
Q3 | $96.3K | Hold |
25,000
| – | – | ﹤0.01% | 635 |
|
|
2024
Q2 | $77.3K | Hold |
25,000
| – | – | ﹤0.01% | 595 |
|
|
2024
Q1 | $64.5K | Hold |
25,000
| – | – | ﹤0.01% | 595 |
|
|
2023
Q4 | $62.5K | Buy |
25,000
+2,000
| +9% | +$5K | ﹤0.01% | 549 |
|
|
2023
Q3 | $46.7K | Buy |
23,000
+4,000
| +21% | +$8.12K | ﹤0.01% | 514 |
|
|
2023
Q2 | $43.7K | Buy |
19,000
+4,000
| +27% | +$9.2K | ﹤0.01% | 533 |
|
|
2023
Q1 | $45.5K | Buy |
15,000
+4,937
| +49% | +$15K | ﹤0.01% | 525 |
|
|
2022
Q4 | $30.3K | Sell |
10,063
-3,026
| -23% | -$9.11K | ﹤0.01% | 451 |
|
|
2022
Q3 | $25K | Buy |
13,089
+3,864
| +42% | +$7.38K | ﹤0.01% | 424 |
|
|
2022
Q2 | $25K | Buy |
+9,225
| New | +$25K | ﹤0.01% | 462 |
|